Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?

Diabetes mellitus is widely recognised as one of the most serious metabolic diseases worldwide, and its incidence in Asian countries is growing at an alarming rate. Type 2 diabetes (T2DM) is closely associated with age, sedentary lifestyle and poor diet. In T2DM, ß-cell dysfunction will occur before...

Full description

Bibliographic Details
Main Authors: Carlessi, Rodrigo, Keane, Kevin, Mamotte, C., Newsholme, Philip
Format: Journal Article
Published: Nature Publishing Group 2017
Online Access:http://hdl.handle.net/20.500.11937/53799
_version_ 1848759230779097088
author Carlessi, Rodrigo
Keane, Kevin
Mamotte, C.
Newsholme, Philip
author_facet Carlessi, Rodrigo
Keane, Kevin
Mamotte, C.
Newsholme, Philip
author_sort Carlessi, Rodrigo
building Curtin Institutional Repository
collection Online Access
description Diabetes mellitus is widely recognised as one of the most serious metabolic diseases worldwide, and its incidence in Asian countries is growing at an alarming rate. Type 2 diabetes (T2DM) is closely associated with age, sedentary lifestyle and poor diet. In T2DM, ß-cell dysfunction will occur before hyperglycaemia develops. Excessive levels of glucose, lipid and various inflammatory factors interact at the level of the pancreatic islet to promote ß-cell dysfunction. Pancreatic ß-cell lines have been widely utilised since the early 1980s and have contributed a large volume of important information regarding molecular, metabolic and genetic mechanisms that regulate insulin secretion. The purpose of this review is to describe the origin and characteristics of the most commonly used ß-cell lines and their contribution to discovery of fundamental regulatory processes that control insulin production and release. Pancreatic islets obtained from rodents as well as other animals have additionally provided information on the architecture and three-dimensional design of this endocrine tissue that allows precise regulation of hormone release. Understanding the nature of failure of physiologic and metabolic processes leading to insufficient insulin release and subsequent diabetes has allowed development of novel anti-diabetic therapeutics, now in common use, worldwide.European Journal of Clinical Nutrition advance online publication, 19 April 2017; doi:10.1038/ejcn.2017.49.
first_indexed 2025-11-14T09:56:35Z
format Journal Article
id curtin-20.500.11937-53799
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:56:35Z
publishDate 2017
publisher Nature Publishing Group
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-537992019-02-19T04:27:05Z Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us? Carlessi, Rodrigo Keane, Kevin Mamotte, C. Newsholme, Philip Diabetes mellitus is widely recognised as one of the most serious metabolic diseases worldwide, and its incidence in Asian countries is growing at an alarming rate. Type 2 diabetes (T2DM) is closely associated with age, sedentary lifestyle and poor diet. In T2DM, ß-cell dysfunction will occur before hyperglycaemia develops. Excessive levels of glucose, lipid and various inflammatory factors interact at the level of the pancreatic islet to promote ß-cell dysfunction. Pancreatic ß-cell lines have been widely utilised since the early 1980s and have contributed a large volume of important information regarding molecular, metabolic and genetic mechanisms that regulate insulin secretion. The purpose of this review is to describe the origin and characteristics of the most commonly used ß-cell lines and their contribution to discovery of fundamental regulatory processes that control insulin production and release. Pancreatic islets obtained from rodents as well as other animals have additionally provided information on the architecture and three-dimensional design of this endocrine tissue that allows precise regulation of hormone release. Understanding the nature of failure of physiologic and metabolic processes leading to insufficient insulin release and subsequent diabetes has allowed development of novel anti-diabetic therapeutics, now in common use, worldwide.European Journal of Clinical Nutrition advance online publication, 19 April 2017; doi:10.1038/ejcn.2017.49. 2017 Journal Article http://hdl.handle.net/20.500.11937/53799 10.1038/ejcn.2017.49 Nature Publishing Group restricted
spellingShingle Carlessi, Rodrigo
Keane, Kevin
Mamotte, C.
Newsholme, Philip
Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
title Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
title_full Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
title_fullStr Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
title_full_unstemmed Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
title_short Nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
title_sort nutrient regulation of ß-cell function: what do islet cell/animal studies tell us?
url http://hdl.handle.net/20.500.11937/53799